IDH2 and central nervous system cancer: The reduced fluorescence observed in IDH-mutant gliomas has been associated with the intracellular accumulation of the oncometabolite 2-HG, which is produced as a result of the neomorphic enzymatic activity of mutant IDH1 and IDH2 isoforms [10].